“The QSP modeling and clinical pharmacology package you used to support our program was instrumental to the success of our study. The deep expertise and patience you brought to the program were game-changing as we now have a state-of-the-art development program for a T cell engager. The QSP-derived starting dose …

“We were excited to have the opportunity to support CDR-Life on their first clinical-stage T cell engager program. It is satisfying to see that we were able to apply our expertise in mechanistic modeling and worked collaboratively with the CDR-Life team to enable their FIH study to start with a …